Ablation of Egr2-positive cells in male mouse anterior pituitary leads to atypical isolated GH deficiency

Endocrinology

Volumn 154, Issue 1, 2013, Pages 272-280

  Bouchoucha, Yassine Xavier ^a,b,c   Charnay, Patrick ^a,b,c   Gilardi Hebenstreit, Pascale ^a,b,c  

^a ECOLE NORMALE SUPÉRIEURE   (France)

^b INSERM   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 2; GLUCOSE; INSULIN; EGR2 PROTEIN, MOUSE; GROWTH HORMONE; SOMATOMEDIN C;

ADENOHYPOPHYSIS; ALLELE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CONTROLLED STUDY; FEMALE; GLUCOSE INTOLERANCE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE SECRETING CELL; HYPOGLYCEMIA; INSULIN SENSITIVITY; MOUSE; MUTANT; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BLOOD; CYTOLOGY; HYPOPITUITARISM; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; PATHOLOGY;

ALLELES; ANIMALS; EARLY GROWTH RESPONSE PROTEIN 2; GROWTH HORMONE; HYPOPITUITARISM; IMMUNOHISTOCHEMISTRY; INSULIN-LIKE GROWTH FACTOR I; MALE; MICE; PITUITARY GLAND, ANTERIOR;

EID: 84871694537     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2012-1792     Document Type: Article

References (64)

1. Bilodeau S, Roussel-Gervais A, Drouin J 2009 Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol 29:1895-1908
2. Davis SW, Mortensen AH, Camper SA 2011 Birthdating studies reshape models for pituitary gland cell specification. Dev Biol 352:215-227
3. Rizzoti K, Lovell-Badge R 2005 Early development of the pituitary gland: induction and shaping of Rathke's pouch. Rev Endocr Metab Disord 6:161-172 (Pubitemid 41285594)
4. Kelberman D, Rizzoti K, Lovell-Badge R, Robinson IC, Dattani MT 2009 Genetic regulation of pituitary gland development in human and mouse. Endocr Rev 30:790-829
5. Zhu X, Gleiberman AS, Rosenfeld MG 2007 Molecular physiology of pituitary development: signaling and transcriptional networks. Physiol Rev 87:933-963 (Pubitemid 47084673)
6. Mathioudakis N, Salvatori R 2008 Adult-onset growth hormone deficiency: causes, complications and treatment options. Curr Opin Endocrinol Diabetes Obes 15:352-358
7. Lucidi P, Lauteri M, Laureti S, Celleno R, Santoni S, Volpi E, Angeletti G, Santeusanio F, De Feo P 1998 A dose-response study of growth hormone (GH) replacement on whole body protein and lipid kinetics in GH-deficient adults. J Clin Endocrinol Metab 83:353-357 (Pubitemid 28496505)
8. Abs R, Mattsson AF, Bengtsson B-Å, Feldt-Rasmussen U, Góth MI, Koltowska-Häggström M, Monson JP, Verhelst J, Wilton P 2005 Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database. Growth Horm IGF Res 15:349-359 (Pubitemid 41408413)
9. Verhelst J, Mattsson AF, Luger A, Thunander M, Góth MI, Koltowska-Häggström M, Abs R 2011 Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis. Eur J Endocrinol 165:881-889
10. Vijayakumar A, Novosyadlyy R, Wu Y, Yakar S, LeRoith D 2010 Biological effects of growth hormone on carbohydrate and lipid metabolism. Growth Horm IGF Res 20:1-7
11. Doga M, Bonadonna S, Gola M, Mazziotti G, Giustina A 2006 Growth hormone deficiency in the adult. Pituitary 9:305-311 (Pubitemid 44823897)
12. Groop L, Segerlantz M, Bramnert M 2005 Insulin sensitivity in adults with growth hormone deficiency and effect of growth hormone treatment. Horm Res 64:45-50 (Pubitemid 43163312)
13. Camper SA, Saunders TL, Katz RW, Reeves RH 1990 The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 8:586-590
14. Li S, Crenshaw III EB, Rawson EJ, Simmons DM, Swanson LW, RosenfeldMG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347:528-533
15. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carrière C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG 1996 Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 384:327-333 (Pubitemid 26408507)
16. Fleenor D, Oden J, Kelly PA, Mohan S, Alliouachene S, Pende M, Wentz S, Kerr J, Freemark M 2005 Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology 146:103-112 (Pubitemid 40051729)
17. Charlton HM, Clark RG, Robinson IC, Goff AE, Cox BS, Bugnon C, Bloch BA 1988 Growth hormone-deficient dwarfism in the rat: a new mutation. J Endocrinol 119:51-58
18. Chandrashekar V, Bartke A 1998 The role of growth hormone in the control of gonadotropin secretion in adult male rats. Endocrinology 139:1067-1074 (Pubitemid 28510124)
19. Bartke A 1999 Role of growth hormone and prolactin in the control of reproduction: what are we learning from transgenic and knockout animals? Steroids 64:598-604 (Pubitemid 29424096)
20. Baker J, Hardy MP, Zhou J, Bondy C, Lupu F, Bellvé AR, Efstratiadis A 1996 Effects of an Igf1 gene null mutation on mouse reproduction. Mol Endocrinol 10:903-918 (Pubitemid 26236351)
21. Zhou Y, Xu BC, Maheshwari HG, He L, Reed M, Lozykowski M, Okada S, Cataldo L, Coschigamo K, Wagner TE, Baumann G, Kopchick JJ 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94:13215-13220 (Pubitemid 27518502)
22. Behringer RR, Mathews LS, Palmiter RD, Brinster RL 1988 Dwarf mice produced by genetic ablation of growth hormone-expressing cells. Genes Dev 2:453-461
23. Luque RM, Lin Q, Córdoba-Chacón J, Subbaiah PV, Buch T, Waisman A, Vankelecom H, Kineman RD 2011 Metabolic impact of adult-onset, isolated, growth hormone deficiency (AOiGHD) due to destruction of pituitary somatotropes. PLoS ONE 6:e15767
24. Chavrier P, Zerial M, Lemaire P, Almendral J, Bravo R, Charnay P 1988 A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J 7:29-35
25. Chavrier P, Lemaire P, Revelant O, Bravo R, Charnay P 1988 Characterization of a mouse multigene family that encodes zinc finger structures. Mol Cell Biol 8:1319-1326
26. Joseph LJ, Le Beau MM, Jamieson Jr GA, Acharya S, Shows TB, Rowley JD, Sukhatme VP 1988 Molecular cloning, sequencing, and mapping of EGR2, a human early growth response gene encoding a protein with "zinc-binding finger" structure. Proc Natl Acad Sci USA 85:7164-7168
27. Voiculescu O, Taillebourg E, Pujades C, Kress C, Buart S, Charnay P, Schneider-Maunoury S 2001 Hindbrain patterning: Krox20 couples segmentation and specification of regional identity. Development 128:4967-4978 (Pubitemid 34083026)
28. Giudicelli F, Taillebourg E, Charnay P, Gilardi-Hebenstreit P 2001 Krox-20 patterns the hindbrain through both cell-autonomous and non cell-autonomous mechanisms. Genes Dev 15:567-580 (Pubitemid 32205145)
29. Worley PF, Bhat RV, Baraban JM, Erickson CA, McNaughton BL, Barnes CA 1993 Thresholds for synaptic activation of transcription factors in hippocampus: correlation with long-term enhancement. J Neurosci 13:4776-4786 (Pubitemid 23326347)
30. Safford M, Collins S, Lutz MA, Allen A, Huang CT, Kowalski J, Blackford A, Horton MR, Drake C, Schwartz RH, Powell JD 2005 Egr-2 and Egr-3 are negative regulators of T cell activation. Nat Immunol 6:472-480 (Pubitemid 41716760)
31. Gibbs JD, Liebermann DA, Hoffman B 2008 Egr-1 abrogates the E2F-1 block in terminal myeloid differentiation and suppresses leukemia. Oncogene 27:98-106
32. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van Evercooren A, Chennoufi AB, Seitanidou T, Babinet C, Charnay P 1994 Krox-20 controls myelination in the peripheral nervous system. Nature 371:796-799 (Pubitemid 24333867)
33. Levi G, Topilko P, Schneider-Maunoury S, Lasagna M, Mantero S, Cancedda R, Charnay P 1996 Defective bone formation in Krox-20 mutant mice. Development 122:113-120 (Pubitemid 26038423)
34. Tourtellotte WG, Milbrandt J 1998 Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. Nat Genet 20:87-91 (Pubitemid 28410352)
35. Christy BA, Lau LF, Nathans D 1988 A gene activated in mouse 3T3 cells by serum growth factors encodes a protein with "zinc finger" sequences. Proc Natl Acad Sci USA 85:7857-7861
36. Lemaire P, Revelant O, Bravo R, Charnay P 1988 Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci USA 85:4691-4695
37. Sukhatme VP, Cao XM, Chang LC, Tsai-Morris CH, Stamenkovich D, Ferreira PC, Cohen DR, Edwards SA, Shows TB, Curran T 1988 A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell 53:37-43
38. Milbrandt J 1987 A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science 238:797-799 (Pubitemid 18005238)
39. Lawson MA, Tsutsumi R, Zhang H, Talukdar I, Butler BK, Santos SJ, Mellon PL, Webster NJG 2007 Pulse sensitivity of the luteinizing hormone β promoter is determined by a negative feedback loop Involving early growth response-1 and Ngfi-A binding protein 1 and 2. Mol Endocrinol 21:1175-1191 (Pubitemid 46984767)
40. Topilko P, Schneider-Maunoury S, Levi G, Trembleau A, Gourdji D, DriancourtMA,Rao CV, Charnay P 1998 Multiple pituitary and ovarian defects in Krox-24 (NGFI-A, Egr-1)-targeted mice. Mol Endocrinol 12:107-122 (Pubitemid 28124784)
41. Lee SL, Sadovsky Y, Swirnoff AH, Polish JA, Goda P, Gavrilina G, Milbrandt J 1996 Luteinizing hormone deficiency and female infertility in mice lacking the transcription factor NGFI-A (Egr-1). Science 273:1219-1221 (Pubitemid 26293210)
42. Olson LE, Tollkuhn J, Scafoglio C, Krones A, Zhang J, Ohgi KA, Wu W, Taketo MM, Kemler R, Grosschedl R, Rose D, Li X, Rosenfeld MG 2006 Homeodomain-mediated β-catenin-dependent switching events dictate cell-lineage determination. Cell 125:593-605
43. Vermeren M, Maro GS, Bron R, McGonnell IM, Charnay P, Topilko P, Cohen J 2003 Integrity of developing spinal motor columns is regulated by neural crest derivatives at motor exit points. Neuron 37:403-415 (Pubitemid 36183363)
44. Schneider-Maunoury S, Topilko P, Seitandou T, Levi G, Cohen-Tannoudji M, Pournin S, Babinet C, Charnay P 1993 Disruption of Krox-20 results in alteration of rhombomeres 3 and 5 in the developing hindbrain. Cell 75:1199-1214 (Pubitemid 24006116)
45. Taillebourg E, Buart S, Charnay P 2002 Conditional, floxed allele of the Krox20 gene. Genesis 32:112-113 (Pubitemid 34211712)
46. Chatonnet F, Wrobel LJ, Mézières V, Pasqualetti M, Ducret S, Taillebourg E, Charnay P, Rijli FM, Champagnat J 2007 Distinct roles of Hoxa2 and Krox20 in the development of rhythmic neural networks controlling inspiratory depth, respiratory frequency, and jaw opening. Neural Dev 2:19
47. del Rincon JP, Iida K, Gaylinn BD, McCurdy CE, Leitner JW, Barbour LA, Kopchick JJ, Friedman JE, Draznin B, Thorner MO 2007 Growth hormone regulation of p85α expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes 56:1638-1646 (Pubitemid 46842597)
48. Jensen DR, Gayles EC, Ammon S, Phillips R, Eckel RH 2001 A self-correcting indirect calorimeter system for the measurement of energy balance in small animals. J Appl Physiol 90:912-918 (Pubitemid 32171375)
49. Riachi M, Himms-Hagen J, Harper ME 2004 Percent relative cumulative frequency analysis in indirect calorimetry: application to studies of transgenic mice. Can J Physiol Pharmacol 82:1075-1083 (Pubitemid 40343644)
50. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D 2002 Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-1 and IRS-2 in liver of Ames dwarf mice. J Endocrinol 173:81-94 (Pubitemid 34428894)
51. Dominici FP, Arostegui Diaz G, Bartke A, Kopchick JJ, Turyn D 2000 Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol 166:579-590
52. Jørgensen JO, Krag M, Jessen N, Nørrelund H, Vestergaard ET, Møller N, Christiansen JS 2004 Growth hormone and glucose homeostasis. Horm Res 62:51-55
53. Riedl M, Ludvik B, Pacini G, Clodi M, Kotzmann H, Wagner O, Kautzky-Willer A, Prager R, Luger A 2000 The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. Eur J Clin Invest 30:771-778. Wiley Online Library
54. Oliveira CR, Salvatori R, Barreto-Filho JA, Rocha IE, Mari A, Pereira RM, Campos VC, Menezes M, Gomes E, Meneguz-Moreno RA, Araújo VP, Leite NT, Nascimento-Junior AC, Farias MI, Viscente TA, Araújo RD, Melo EV, Aguiar-Oliveira MH 2012 Insulin sensitivity and -cell function in adults with lifetime, untreated isolated growth hormone deficiency. J Clin Endocrinol Metab 97:1013-1019
55. Mauras N, O'Brien KO, Welch S, Rini A, Helgeson K, Vieira NE, Yergey AL 2000 Insulin-like growth factor I and growth hormone (GH) treatment in GH-deficient humans: differential effects on protein, glucose, lipid, and calcium metabolism. J Clin Endocrinol Metab 85:1686-1694 (Pubitemid 32289519)
56. Boyle PJ, Avogaro A, Smith L, Shah SD, Cryer PE, Santiago JV 1992 Absence of the dawn phenomenon and abnormal lipolysis in type 1 (insulin-dependent) diabetic patients with chronic growth hormone deficiency. Diabetologia 35:372-379
57. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D 2004 Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 113:96-105 (Pubitemid 38541636)
58. Sasaki-Suzuki N, Arai K, Ogata T, Kasahara K, Sakoda H, Chida K, Asano T, Pessin JE, Hakuno F, Takahashi S-I 2009 Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway. J Biol Chem 284:6061-6070
59. Kelley DE, Mandarino LJ 2000 Fuel selection in human skeletal muscle in insulin resistance: a reexamination. Diabetes 49:677-683 (Pubitemid 30339979)
60. Storlien L, Oakes ND, Kelley DE 2004 Metabolic flexibility. Proc Nutr Soc 63:363-368 (Pubitemid 38787491)
61. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK 2005 Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 115:3564-3572 (Pubitemid 43121844)
62. Wortley KE, del Rincon JP, Murray JD, Garcia K, Iida K, Thorner MO, Sleeman MW 2005 Absence of ghrelin protects against early-onset obesity. J Clin Invest 115:3573-3578 (Pubitemid 43121845)
63. Longo KA, Charoenthongtrakul S, Giuliana DJ, Govek EK, McDonagh T, Qi Y, DiStefano PS, Geddes BJ 2008 Improved insulin sensitivity and metabolic flexibility in ghrelin receptor knockout mice. Regul Pept 150:55-61
64. Huda MS, Dovey TM, Wong SP, English PJ, Halford JC, McCulloch P, Cleator J, Martin B, Cashen J, Hayden K, Ghatei MA, Bloom SR, Wilding JP, Pinkney JH 2011 Ghrelin does not orchestrate the metabolic changes seen in fasting but has significant effects on lipid mobilisation and substrate utilisation. Eur J Endocrinol 165:45-55